PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Endocrinology and Metabolism10.3803/enm.2021.10742021364823-834Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center CohortsJiwon Kim, Minyoung Lee, Soo Yeon Kim, Ji-Hye Kim, Ji Sun Nam, Sung Wan Chun, Se Eun Park, Kwang Joon Kim, Yong-ho Lee, Joo Young Nam, Eun Seok Kanghttp://e-enm.org/upload/pdf/enm-2021-1074.pdf, http://e-enm.org/journal/view.php?doi=10.3803/EnM.2021.1074, http://e-enm.org/upload/pdf/enm-2021-1074.pdf
Hepatology10.1002/hep.306702019Incretin‐Based Therapies for the Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 DiabetesKenneth Cusihttps://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.30670, https://onlinelibrary.wiley.com/doi/full-xml/10.1002/hep.30670, https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.30670
Pediatric Type II Diabetes10.1016/b978-0-323-55138-0.00011-5201991-99Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) and Type 2 DiabetesAlfonso Galderisi, Mariangela Martino, Nicola Santorohttps://api.elsevier.com/content/article/PII:B9780323551380000115?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B9780323551380000115?httpAccept=text/plain
Diabetes Research and Clinical Practice10.1016/s0168-8227(14)70603-52014106S205PO309 LIMITATION OF THE DIAGNOSTIC SCREENING TOOL FOR NONALCOHOLIC STEATOHEPATITIS IN NON-OBESE JAPANESE PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASEA. Nakamura, M. Yoneda, Y. Sumida, H. Miyoshi, A. Nakajima, T. Atsumi, Y. Terauchihttps://api.elsevier.com/content/article/PII:S0168822714706035?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0168822714706035?httpAccept=text/plain
Journal of Diabetes and its Complications10.1016/j.jdiacomp.2021.1079782021359107978Non-invasive diagnosis of nonalcoholic fatty liver disease in patients with type 2 diabetesAlshaima Alhinai, Keyur Patel, Vivian A. Fonseca, Giada Sebastianihttps://api.elsevier.com/content/article/PII:S1056872721001756?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1056872721001756?httpAccept=text/plain
The Journal of Korean Diabetes10.4093/jkd.2018.19.2.97201819297Pharmacologic Treatment Using Non-Hypoglycemic Agents for Nonalcoholic Fatty Liver DiseaseSeung Up Kimhttps://synapse.koreamed.org/pdf/10.4093/jkd.2018.19.2.97, https://synapse.koreamed.org/DOIx.php?id=10.4093/jkd.2018.19.2.97, https://e-jkd.org/DOIx.php?id=10.4093/jkd.2018.19.2.97
Hepatology Communications10.1002/hep4.1618202052158-167Nonalcoholic Fatty Liver Disease Screening in Type 2 Diabetes Mellitus Patients in the Primary Care SettingJoana Vieira Barbosa, Michelle Laihttps://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1618, https://onlinelibrary.wiley.com/doi/full-xml/10.1002/hep4.1618, https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1618
Diabetes Research and Clinical Practice10.1016/j.diabres.2020.1083582020167108358Screening strategies for nonalcoholic fatty liver disease in type 2 diabetes: Insights from NHANES 2005–2016Stefano Ciardullo, Isabella Sala, Gianluca Perseghinhttps://api.elsevier.com/content/article/PII:S0168822720306100?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0168822720306100?httpAccept=text/plain
Diabetic Medicine10.1111/j.1464-5491.2011.03427.x2012292220-226Increased prevalence of chronic kidney disease in patients with Type 1 diabetes and non-alcoholic fatty liverG. Targher, I. Pichiri, G. Zoppini, M. Trombetta, E. Bonorahttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1464-5491.2011.03427.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-5491.2011.03427.x/fullpdf
Diabetes10.2337/db18-1853-p201867Supplement 11853-PElevated Serum Cytokeratin-18 Levels in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver DiseaseTAO-CHUN LEEhttps://syndication.highwire.org/content/doi/10.2337/db18-1853-P